Strings of epitopes useful in diagnosing and eliciting immune responses to sexually transmitted infections
US-9910042-B2 · Mar 6, 2018 · US
US10386369B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-10386369-B2 |
| Application number | US-201815877635-A |
| Country | US |
| Kind code | B2 |
| Filing date | Jan 23, 2018 |
| Priority date | Mar 13, 2013 |
| Publication date | Aug 20, 2019 |
| Grant date | Aug 20, 2019 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
The invention provides methods and compositions for detecting and diagnosing sexually transmitted infections using a string of epitopes (SOE) specific for detection of causative microorganisms. The antigenic epitopes may be single epitope sequences, a plurality of epitope sequences joined by repeats of glycine (-GG-) and/or lysine (-KK-) to form a series of epitopes (SOE), or nucleotide sequences encoding one or more SOEs and host cells harboring said SOE nucleotide sequences. SOEs specific for highly immunogenic regions of proteins from Trichomonas, Treponema and Neisseria species are provided. SOEs to detect the presence of trichomonas species comprise regions from Trichomonas-sptciric aldolase, GAPDH, a-enolase and a-actinin proteins. Pharmaceutical compositions comprising SOEs can also be used as vaccines or to elicit an immune response to specific microorganisms.
Opening claim text (preview).
What is claimed is: 1. A method for detecting the presence of one or more Trichomonas vaginalis microorganisms in a biological sample of a subject, comprising the steps of: combining said biological sample with a polypeptide including a series of epitopes (SOE) which includes at least a plurality of epitopes selected from the group consisting of SEQ ID NO: 2, SEQ ID NO: 21, SEQ ID NO: 22, SEQ ID NO: 23, SEQ ID NO: 24, SEQ ID NO: 26, SEQ ID NO: 27, SEQ ID NO: 28, SEQ ID NO: 29, SEQ ID NO: 30, SEQ ID NO: 35, SEQ ID NO: 36, SEQ ID NO: 37, SEQ ID NO: 38, SEQ ID NO: 39, SEQ ID NO: 40, SEQ ID NO: 41, SEQ ID NO: 44, SEQ ID NO:82, and SEQ ID NO: 137, said epitopes being arranged as a linear array with each of said epitopes being connected by an amino acid linker consisting of a repeat of an amino acid, wherein said combining is performed under conditions whereby antigen-antibody complexes are permitted to form; and detecting formation of at least one antigen-antibody complex as an indication of a presence of at least one microorganism of said one or more Trichomonas vaginalis microorganisms in said biological sample. 2. The method of claim 1 , wherein said Trichomonas vaginalis microrganisms are selected from the group consisting of T. vaginalis isolates T016, T068-II, UT40, and VB102. 3. The method of claim 1 , wherein said detecting step is performed using an immunoassay. 4. The method of claim 3 , wherein said immunoassay is an enzyme-linked immunosorbent assay (ELISA). 5. The method of claim 1 , wherein said biological sample is selected from the group consisting of serum, plasma, blood, saliva, semen, cerebrospinal fluid, semen, prostatic fluid, urine, sputum, joint fluid, body cavity fluid, whole cells, cell extracts, tissue, biopsy material, aspirates, exudates, vaginal washings, pap smear samples, pap smear preparations, slide preparations, fixed cells, and tissue sections. 6. The method of claim 1 , wherein said subject is selected from the group of human, non-human primate, dog, cat, cattle, sheep, swine, horse, bird, mouse and rat. 7. A polypeptide including a series of epitopes (SOE) which includes at least a plurality of epitopes selected from the group consisting of SEQ ID NO: 2, SEQ ID NO: 21, SEQ ID NO: 22, SEQ ID NO: 23, SEQ ID NO: 24, SEQ ID NO: 26, SEQ ID NO: 27, SEQ ID NO: 28, SEQ ID NO: 29, SEQ ID NO: 30, SEQ ID NO: 35, SEQ ID NO: 36, SEQ ID NO: 37, SEQ ID NO: 38, SEQ ID NO: 39, SEQ ID NO: 40, SEQ ID NO: 41, SEQ ID NO: 44, SEQ ID NO:82, and SEQ ID NO: 137 said epitopes being arranged as a linear array with each of said epitopes being connected by an amino acid linker consisting of a repeat of an amino acid. 8. A kit for detecting the presence of one or more Trichomonas vaginalis microorganisms comprising at least one polypeptide of claim 7 and assay reagents or media for detecting formation of at least one antigen-antibody complex comprising said at least one polypeptide. 9. A method of eliciting an immune response to a Trichomonas vaginalis microorganism in a subject, comprising the steps of preparing a pharmaceutical composition comprising at least one SOE, which includes at least a plurality of epitopes selected from the group consisting of SEQ ID NO: 2, SEQ ID NO: 21, SEQ ID NO: 22, SEQ ID NO: 23, SEQ ID NO: 24, SEQ ID NO: 26, SEQ ID NO: 27, SEQ ID NO: 28, SEQ ID NO: 29, SEQ ID NO: 30, SEQ ID NO: 35, SEQ ID NO: 36, SEQ ID NO: 37, SEQ ID NO: 38, SEQ ID NO: 39, SEQ ID NO: 40, SEQ ID NO: 41, SEQ ID NO: 44, SEQ ID NO:82, and SEQ ID NO: 137, said epitopes being arranged as a linear array with each of said epitopes being connected by an amino acid linker consisting of a repeat of an amino acid , and a suitable carrier and adjuvant, and administering said pharmaceutical composition to said subject in an amount sufficient to stimulate formation of antibodies to said SOE by the immune system of said subject.
from protozoa · CPC title
from Spirochaetales (O), e.g. Treponema, Leptospira · CPC title
containing a tag for immunodetection, or an epitope for immunisation · CPC title
from Neisseriaceae (F) · CPC title
from Neisseriaceae (F), e.g. Acinetobacter · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.